What do we know about extracellular vesicles in patients with idiopathic pulmonary fibrosis? a scoping review

What do we know about extracellular vesicles in patients with idiopathic pulmonary fibrosis? a scoping review

Extracellular Vesicles (EVs), released by all cell types and detectable in biological samples, carry a variety of biological molecules. These molecules mediate communication and signaling with both local and distant cells, potentially playing a role in the pathogenesis of diseases, including Interst...

Full description

Saved in:

Bibliographic Details
Main Authors:	Maria Conti, Alvise Casara, Graziella Turato, Simonetta Baraldo, Mariaenrica Tinè, Umberto Semenzato, Elisabetta Cocconcelli, Davide Biondini, Marco Damin, Marina Saetta, Manuel G. Cosio, Elisabetta Balestro, Paolo Spagnolo, Erica Bazzan, Nicol Bernardinello
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-07-01
Series:	Frontiers in Immunology
Subjects:	extracellular vesicles interstitial lung diseases MISEV idiopathic pulmonary fibrosis lung fibrosis
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1541645/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Idiopathic Pulmonary Fibrosis, Today and Tomorrow: Certainties and New Therapeutic Horizons
by: Giacomo Giulianelli, et al.
Published: (2025-05-01)

Predicting biomarkers of progressive pulmonary fibrosis: morphological, cytokine profile, and clinical portrait
by: Nicol Bernardinello, et al.
Published: (2025-06-01)

The Intricate Relationship Between Pulmonary Fibrosis and Thrombotic Pathology: A Narrative Review
by: Giovanni Cenerini, et al.
Published: (2024-12-01)

Neutrophils and Lymphocytes: Yin and Yang of Lung Fibrosis and Patient Outcome in Diffuse Interstitial Lung Diseases
by: Erika M. Novoa-Bolivar, et al.
Published: (2024-10-01)

Oxaliplatin-induced lung fibrosis
by: Shah Arpan, et al.
Published: (2009-01-01)

Lung Fibrosis Sequelae After Recovery from COVID-19 Infection
by: Agus Dwi Susanto, et al.
Published: (2021-03-01)

Development and evaluation of a questionnaire to capture environmental and occupational inhalational exposures in adults with fibrotic interstitial lung disease
by: Aparna C Swaminathan, et al.
Published: (2024-10-01)

Validation of the gender, age, physiology model and other prognostic factors in interstitial lung disease patients with systemic autoimmune rheumatic disease
by: Yun Jung Hwang, et al.
Published: (2025-07-01)

Impact of CFTR Modulators on Longitudinal Cystic Fibrosis Survival and Mortality: Review and Secondary Analysis
by: Jaime L. Rubin, et al.
Published: (2025-07-01)

Serum inflammatory markers as predictors of therapeutic response in non-idiopathic pulmonary fibrosis fibrotic interstitial lung disease: a retrospective cohort analysis
by: Yanisa Kluanwan, et al.
Published: (2025-05-01)

Fluorofenidone alleviates cigarette smoke exposure-induced chronic lung injury by targeting ferroptosis
by: Yuan Wu, et al.
Published: (2024-12-01)

Context‐specific anti‐inflammatory roles of type III interferon signaling in the lung in nonviral injuries
by: Jingjing Feng, et al.
Published: (2024-10-01)

Swine Flu Progressive Pulmonary Fibrosis – Clinical Manifestation and Morphology of Explanted Lungs
by: Shirish Sahebrao Chandanwale, et al.
Published: (2025-04-01)

Lung disease in relation to unique monocyte-macrophage subpopulations induced by combined inhalant endotoxin and collagen-induced arthritis
by: Jill A. Poole, et al.
Published: (2025-04-01)

Association between radiological sequelae and functional impairment in post-pulmonary tuberculosis patients at a tertiary care center
by: Khusboo Bihani, et al.
Published: (2025-01-01)

Nutritional status in patients with cystic fi brosis before and after lung transplantation
by: M. Sh. Khubutiya, et al.
Published: (2017-06-01)

Single lung transplantation for pulmonary fibrosis: Does side matter?
by: Frank Langer, et al.
Published: (2025-05-01)

Impact of elexacaftor/tezacaftor/ivacaftor on the small airways in cystic fibrosis
by: Sofia Campos Silva, et al.
Published: (2025-06-01)

Brief communication: Chest radiography score in young COVID-19 patients: Does one size fit all?
by: Gioele Castelli, et al.
Published: (2022-01-01)

Interstitial lung diseases: a view on the problem
by: O. G. Sych, et al.
Published: (2025-06-01)

Fibrotic Hypersensitivity Pneumonitis: A Diagnostic Challenge Leading to Lung Transplantation
by: Maria-Daniela Mot, et al.
Published: (2025-05-01)

Long-Term Follow-Up of Interstitial Lung Abnormalities in Low-Dose Chest CT in Health Screening: Exploring the Predictors of Clinically Significant Interstitial Lung Diseases Using Artificial Intelligence-Based Quantitative CT Analysis
by: Won Jong Jeong, et al.
Published: (2024-11-01)

Accelerating extracellular vesicle research and biotechnological applications using synthetic biology approaches
by: Richard J.R. Kelwick, et al.
Published: (2024-12-01)

Organising Pneumonia in a Patient Following Obinutuzumab for Follicular Lymphoma
by: Viral Nanda, et al.
Published: (2025-06-01)

Peripheral and pulmonary telomere lengths in patients with non-idiopathic pulmonary fibrosis interstitial lung diseases
by: Yujie Shi, et al.
Published: (2025-08-01)

Pulmonary function and body composition parameters of children with cystic fibrosis from a hight complexity institution between 2015 and 2018
by: Aura María Salazar-Solarte, et al.
Published: (2024-11-01)

Computed tomography in evaluating the development of different types of pulmonary fibrosis in patients with interstitial lung diseases
by: A. A. Speranskaya, et al.
Published: (2016-03-01)

Deciphering key nano-bio interface descriptors to predict nanoparticle-induced lung fibrosis
by: Jiayu Cao, et al.
Published: (2025-01-01)

Prevalence of pulmonary arterial hypertension in post-tuberculosis lung fibrosis patients: A cross-sectional observational study
by: Rupak Chatterjee, et al.
Published: (2023-12-01)

Percutaneous endoscopic gastrostomy in comprehensive preparing the patients with severe body mass defciency for lung transplantation
by: M. Sh. Khubutiya, et al.
Published: (2019-03-01)

Drug-Induced Interstitial Lung Disease
by: Wei-I Lee, et al.
Published: (2019-01-01)

Long term azithromycin therapy in patients with cystic fibrosis
by: Nagehan Emiralioğlu, et al.
Published: (2016-02-01)

Outcomes of combined liver-lung transplant in pediatric patients with cystic fibrosis: An ISHLT transplant registry study
by: Renita Wilson, BS, et al.
Published: (2025-02-01)

Lung function trajectories in children with early diagnosis of non-cystic fibrosis bronchiectasis: a retrospective observational study
by: Rossella Lamberti, et al.
Published: (2024-11-01)

Radiological and Clinical Presentation of Interstitial Lung Disease in Patients with Concomitant Psoriasis: A Cross-sectional Study
by: Manoj Meena, et al.
Published: (2025-04-01)

Diagnostic Challenge in a Case of Cryptogenic Organising Pneumonia
by: Shailesh Bhanudas Meshram, et al.
Published: (2025-03-01)

Clinical implications of idiopathic pulmonary fibrosis and lung cancer
by: Hongseok Yoo, et al.
Published: (2025-03-01)

Silicosis: from pathogenesis to therapeutics
by: Bijun Yang, et al.
Published: (2025-01-01)

Loss of interferon regulatory factor-1 prevents lung fibrosis by upregulation of pon1 expression
by: Aiyuan Zhou, et al.
Published: (2024-11-01)

Composition and modification of the lung microbiome in patients with idiopathic pulmonary fibrosis
by: Victoria Maria Ruta, et al.
Published: (2020-10-01)